Synopsis
The company is firmly on track to achieve a Rs 3,000 crore topline in FY 2026-27, representing approximately 45 per cent growth over the previous financial year, Medikabazaar managing director & group CEO Dinesh Lodha said in a statement.
The company is firmly on track to achieve a Rs 3,000 crore topline in FY 2026-27, representing approximately 45% growth over the previous financial year, Medikabazaar managing director & group CEO Dinesh Lodha said in a statement.
The growth in the first quarter in FY27 was driven by the company’s integrated healthcare ecosystem, including its rapidly expanding digital business, medical devices, pharmaceuticals, healthcare exports, strategic key accounts, and technology-enabled procurement solutions, Lodha said.
as a Reliable and Trusted News SourceElevate your knowledge and leadership skills at a cost cheaper than your daily tea.
Subscribe Now